Metropolis Healthcare Ltd. (METROPOLIS): Metropolis Healthcare Share Price rises near 52-week high on NSE
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Metropolis Healthcare Share Price is trading at Rs 598.30, up Rs 13 or 2.22%, and remains close to its 52-week high in early trade on 18 September 2026 at 3:18 PM IST. The company’s market capitalisation stands at Rs 12,043.74 Cr, keeping Metropolis Healthcare Ltd. in focus among healthcare stocks in news today. The latest Univest data confirms a near 52-week high event, but it does not establish a company-specific catalyst.
For readers tracking Metropolis Healthcare Share Price Today, the move is significant because the stock is trading well above its previous close of Rs 585.30 and within sight of its yearly high zone. In this Metropolis Healthcare Stock News update, the price action is factual rather than narrative-driven: the stock opened at Rs 589.65, touched an intraday high of Rs 602 and a low of Rs 589.65, while turnover stood at Rs 0.47 Cr. That combination keeps Metropolis Healthcare Share Price in the market’s attention for share price live monitoring and broader Metropolis Healthcare Share Price news searches.
Metropolis Healthcare Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 598.3 |
| Previous Close | Rs 585.3 |
| Today's Move | +Rs 13 (+2.22%) |
| Open | Rs 589.65 |
| High | Rs 602 |
| Low | Rs 589.65 |
| Turnover | Rs 0.47 crore |
| Market Capitalisation | Rs 12,043.74 crore |
Metropolis Healthcare Ltd. (METROPOLIS) traded at Rs 598.3 versus the previous close of Rs 585.3, a rise of 2.22%. The stock opened at Rs 589.65, reached a high of Rs 602 and touched a low of Rs 589.65.
Metropolis Healthcare Share Price moved from Rs 585.30 to Rs 598.30, which means the stock is Rs 13 above the previous close. The current price is also Rs 2.30 below the day’s high of Rs 602, so the stock is trading close to the upper end of the day’s range. The opening price was Rs 589.65 and the day’s low was also Rs 589.65, which places the current quote above the opening level and near the day high. Turnover at Rs 0.47 Cr gives a clear traded-value reference for the move, while the latest Univest figures confirm that Metropolis Healthcare Share Price is sitting near its 52-week high without claiming a new yearly record. For investors scanning Metropolis Healthcare Share Price Today, the main fact is simple: price has stayed firm around the upper band of the current range. That sets up the next question of valuation and company quality in Metropolis Healthcare Stock Analysis.
Metropolis Healthcare Ltd. (METROPOLIS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 12,043.74 crore |
| P/E Ratio | 60.22x |
| P/B Ratio | 7.79x |
| ROE | 13.53% |
| ROCE | 20.03% |
| EPS | Rs 9.72 |
| Book Value Per Share | Rs 75.16 |
| Dividend Yield | 0.85% |
Metropolis Healthcare Ltd. (METROPOLIS) fundamental metrics show P/E 60.22x, P/B 7.79x, ROE 13.53%, ROCE 20.03%. These figures provide context only and are not a buy or sell signal.
Metropolis Healthcare Ltd. has a market capitalisation of Rs 12043.74 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 60.22x, P/B at 7.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.53% and ROCE of 20.03%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 9.72, book value per share of Rs 75.16, dividend yield of 0.85%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 41.13x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 60.22x |
| Benchmark Median P/E | 41.13x |
| Benchmark Average P/E | 88.82x |
| Benchmark P/E Range | 0x to 1,561.8x |
| Company P/B Ratio | 7.79x |
| Benchmark Median P/B | 3.67x |
| Company ROE | 13.53% |
| Benchmark Median ROE | 13.01% |
| Company ROCE | 20.03% |
| Benchmark Median ROCE | 15.84% |
| Company Market Capitalisation | Rs 12,043.74 crore |
| Benchmark Median Market Cap | Rs 481.69 crore |
Metropolis Healthcare Ltd. (METROPOLIS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Metropolis Healthcare Ltd. (METROPOLIS) has a P/E ratio of 60.22x, which is above the benchmark median of 41.13x, a difference of +46.41%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Metropolis Healthcare Ltd. (METROPOLIS) has a ROE of 13.53%, which is above the benchmark median of 13.01%, a difference of +4%. Metropolis Healthcare Ltd. (METROPOLIS) has a ROCE of 20.03%, which is above the benchmark median of 15.84%, a difference of +26.45%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| PARK MEDI WORLD LIMITED | PARKHOSPS | 11,929.93 | 46.59 | 5.73 | 17.94 | 21.3 |
| Healthcare Global Enterprises Ltd. | HCG | 10,081.63 | 451.87 | 7.64 | 2.04 | 9.77 |
| Rainbow Children's Medicare Ltd. | RAINBOW | 14,796.23 | 52.39 | 8.76 | 18.1 | 28.25 |
| Vijaya Diagnostic Centre Ltd. | VIJAYA | 14,803.35 | 82.79 | 15.41 | 19.91 | 30.28 |
| Yatharth Hospital & Trauma Care Services Ltd. | YATHARTH | 9,469.71 | 56.93 | 5.65 | 10.06 | 13.3 |
Metropolis Healthcare Ltd. (METROPOLIS) has a P/E ratio of 60.22x compared with the displayed peer median of 56.93x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.53% compares with a peer median of 17.94% across the companies shown in the table. ROCE stood at 20.03% versus the displayed peer median of 21.3%, providing a capital-efficiency comparison. Metropolis Healthcare Ltd. (METROPOLIS) has a market capitalisation of Rs 12,043.74 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Metropolis Healthcare
- Metropolis Healthcare Share Price is trading at Rs 598.30, up 2.22% from the previous close of Rs 585.30.
- The stock is near its 52-week high, keeping Metropolis Healthcare Share Price in focus in Stocks in News.
- Market capitalisation stands at Rs 12,043.74 Cr, which frames the company’s size in the healthcare segment.
- P/E is 60.22 and P/B is 7.79, both above the same-industry median in latest Univest figures.
- ROE of 13.53% and ROCE of 20.03% provide return context for Metropolis Healthcare Share Price Today.
About Metropolis Healthcare
Metropolis Healthcare Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company name, sector and industry classification are the key verified business identifiers in this article. Metropolis Healthcare Share Price is therefore being read within a healthcare-services context rather than as a broad market proxy. For readers following Metropolis Healthcare Company News, this is the relevant operating classification attached to the listed entity.
Frequently Asked Questions
Why is Metropolis Healthcare Share Price near the 52-week high?
Ans. Metropolis Healthcare Share Price is trading at Rs 598.30, close to its yearly high zone. The latest Univest figures also show a 2.22% rise versus the previous close of Rs 585.30.
What is Metropolis Healthcare Share Price today?
Ans. Metropolis Healthcare Share Price today is Rs 598.30. The stock is up Rs 13 or 2.22% from the previous close, with the day’s high at Rs 602 and low at Rs 589.65.
How does Metropolis Healthcare Share Price compare with its market capitalisation?
Ans. Metropolis Healthcare Share Price is backed by a market capitalisation of Rs 12,043.74 Cr. That places the company above the industry median market cap in the same-industry benchmark set.
What does Metropolis Healthcare fundamental analysis show?
Ans. Metropolis Healthcare fundamental analysis shows a P/E of 60.22, P/B of 7.79, ROE of 13.53%, ROCE of 20.03%, EPS of 9.72 and book value of Rs 75.16, with dividend yield at 0.85%.
How does Metropolis Healthcare compare with healthcare peers?
Ans. Metropolis Healthcare Share Price sits in the middle of the listed peer market-cap range. Its P/E is higher than Park Medi World and Yatharth, but below Healthcare Global Enterprises and DR Agarwals Health Care.
What revenue trend is visible in Metropolis Healthcare financial results?
Ans. Metropolis Healthcare financial results show revenue of Rs 3,860.63 Cr in June 2025, Rs 4,291.91 Cr in September 2025, Rs 4,059.10 Cr in December 2025, Rs 4,246.82 Cr in March 2026 and Rs 4,502.15 Cr in June 2026.
Is Metropolis Healthcare Share Price expensive relative to peers?
Ans. Metropolis Healthcare Share Price trades on a P/E of 60.22 and P/B of 7.79, both above the same-industry median. That makes it richer than the benchmark midpoint on valuation metrics.
Where can I track Metropolis Healthcare Share Price live?
Ans. You can track Metropolis Healthcare Share Price live on Univest for price updates, market cap, financial ratios, 52-week levels and Metropolis Healthcare Stock News in one place. The stock moved 2.22% so far today.
Track Metropolis Healthcare Share Price on Univest
Use Metropolis Healthcare Ltd. (METROPOLIS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Users can track Metropolis Healthcare Share Price on Univest for live price updates, financial ratios, 52-week levels, market insights and Metropolis Healthcare Stock News. Univest also helps readers follow Metropolis Healthcare Share Price Today alongside company fundamentals, sector context and peer comparisons in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
